14th week of 2021 patent applcation highlights part 7 |
Patent application number | Title | Published |
20210100754 | TRANSDERMAL DRUG DELIVERY SYSTEMS WITH FLUOROSILICONE RELEASE LINERS | 2021-04-08 |
20210100755 | USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY | 2021-04-08 |
20210100756 | METHOD FOR THE TREATMENT OF DISEASES ASSOCIATED WITH SULFATASE DEFICIENCIES | 2021-04-08 |
20210100757 | BISPHENOL ETHER DERIVATIVES AND METHODS FOR USING THE SAME | 2021-04-08 |
20210100758 | Diagnosis and Treatment of Vitiligo | 2021-04-08 |
20210100759 | PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES | 2021-04-08 |
20210100760 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2021-04-08 |
20210100761 | MEDICATION TO ELEVATE SOCIAL AND OCCUPATIONAL FUNCTIONING | 2021-04-08 |
20210100762 | Compositions and methods including reverse thermal gels and pH adjustors | 2021-04-08 |
20210100763 | USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS | 2021-04-08 |
20210100764 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2021-04-08 |
20210100765 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2021-04-08 |
20210100766 | METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE | 2021-04-08 |
20210100767 | COMPOSITIONS FOR PREVENTION OR TREATMENT OF ACUTE RADIATION SYNDROME AND OTHER RADIATION EXPOSURE | 2021-04-08 |
20210100768 | METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT | 2021-04-08 |
20210100769 | PRESERVATIVE-FREE FORMULATIONS OF TETRACAINE HCL | 2021-04-08 |
20210100770 | TRIPLE DRUG COMBINATION (METFORMIN, SIMVASTATIN, DIGOXIN) FOR TARGETED TREATMENT OF PANCREATIC CANCER | 2021-04-08 |
20210100771 | NEW CANNABIS TABLET FORMULATIONS AND COMPOSITIONS AND METHODS OF MAKING THE SAME | 2021-04-08 |
20210100772 | METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA | 2021-04-08 |
20210100773 | METHOD FOR PREVENTING AND/OR TREATING CHRONIC TRAUMATIC ENCEPHALOPATHY-I | 2021-04-08 |
20210100774 | METHODS AND COMPOSITIONS FOR ENHANCING ANTI-TUMOR IMMUNITY BY TARGETING STEROIDOGENESIS | 2021-04-08 |
20210100775 | COMBINATION THERAPIES | 2021-04-08 |
20210100776 | MAGNESIUM BIOTINATE COMPOSITIONS AND METHODS OF USE | 2021-04-08 |
20210100777 | HEAT SHOCK PROTEIN (HSP) INHIBITION AND MONITORING EFFECTIVENESS THEREOF | 2021-04-08 |
20210100778 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH | 2021-04-08 |
20210100779 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | 2021-04-08 |
20210100780 | METHODS FOR TREATING WILD TYPE ISOCITRATE DEHYDROGENASE 1 CANCERS | 2021-04-08 |
20210100781 | TUMOR SUPPRESSION | 2021-04-08 |
20210100782 | PARASITIC PEST CONTROL AGENTS COMPRISING PYRIDONE COMPOUNDS AS ACTIVE INGREDIENTS AND METHODS FOR USING THE SAME | 2021-04-08 |
20210100783 | NOVEL CYCLIN-DEPENDENT KINASE 8 AND/OR 19 INHIBITOR | 2021-04-08 |
20210100784 | PEDIATRIC SUSPENSION FORMULATION | 2021-04-08 |
20210100785 | SOLID FORMS COMPRISING 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF | 2021-04-08 |
20210100786 | Pharmaceutical Formulations | 2021-04-08 |
20210100787 | DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION | 2021-04-08 |
20210100788 | PALONOSETRON FORMULATIONS AND USES THEREOF | 2021-04-08 |
20210100789 | METHOD OF INHIBITING MUTANT C-KIT | 2021-04-08 |
20210100790 | DRUG FOR PREVENTING AND/OR TREATING DEMENTIA | 2021-04-08 |
20210100791 | COMBINED PHARMACEUTICAL FORMULATION COMPRISING DRUG-CONTAINING LIPOSOME COMPOSITION AND IMMUNE CHECKPOINT INHIBITOR | 2021-04-08 |
20210100792 | DOSING REGIMEN FOR INJECTABLE CETIRIZINE | 2021-04-08 |
20210100793 | DOSING REGIMEN FOR INJECTABLE CETIRIZINE | 2021-04-08 |
20210100794 | COMPOSITIONS AND METHODS FOR TREATING CENTRALLY MEDIATED NAUSEA AND VOMITING | 2021-04-08 |
20210100795 | RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION | 2021-04-08 |
20210100796 | DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITOR | 2021-04-08 |
20210100797 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF | 2021-04-08 |
20210100798 | DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITOR | 2021-04-08 |
20210100799 | RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION | 2021-04-08 |
20210100800 | USE OF A COMBINATIONAL THERAPY OF LSD1 INHIBITORS WITH P21 ACTIVATORS IN THE TREATMENT OF CANCER | 2021-04-08 |
20210100801 | PHARMACEUTICAL COMPOSITION FOR STIMULATING STEM CELL DIVISION AND SUPPRESSING BACTERIAL VIRULENCE | 2021-04-08 |
20210100802 | HETEROCYCLIC COMPOUNDS AND USES AS ANTICANCER AGENTS | 2021-04-08 |
20210100803 | METHODS AND COMPOSITIONS FOR TREATING CANCER | 2021-04-08 |
20210100804 | PHARMACEUTICAL COMPOSITION OF PEMETREXED | 2021-04-08 |
20210100805 | COMBINATION THERAPY FOR TREATING MALIGNANCIES | 2021-04-08 |
20210100806 | Compounds and Compositions for Ossification and Methods Related Thereto | 2021-04-08 |
20210100808 | USE OF REBOXETINE TO TREAT NARCOLEPSY | 2021-04-08 |
20210100809 | USE OF REBOXETINE TO TREAT NARCOLEPSY | 2021-04-08 |
20210100810 | COMBINATION THERAPY FOR TREATING CANCER | 2021-04-08 |
20210100811 | METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE | 2021-04-08 |
20210100812 | Methods for Treating EGFR Mutant Cancers | 2021-04-08 |
20210100813 | COMBINATION THERAPY FOR CANCER USING BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITORS | 2021-04-08 |
20210100814 | Use of GABAA receptor modulators for treatment of itch | 2021-04-08 |
20210100815 | METHODS OF TREATING HYPOGONADISM WITH TRANSNASAL TESTOSTERONE BIO-ADHESIVE GEL FORMULATIONS IN MALE WITH ALLERGIC RHINITIS, AND METHODS FOR PREVENTING AN ALLERGIC RHINITIS EVENT | 2021-04-08 |
20210100816 | Steroidal Compositions | 2021-04-08 |
20210100817 | ANTICONVULSANT ACTIVITY OF STEROIDS | 2021-04-08 |
20210100818 | Budesonide Prodrug | 2021-04-08 |
20210100819 | PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES TO THE RECTUM | 2021-04-08 |
20210100820 | S1PR4-TARGETING COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | 2021-04-08 |
20210100821 | STABLE LYOPHILIZED COMPOSITION OF CYCLOPHOSPHAMIDE | 2021-04-08 |
20210100822 | Synthetic Composition for Treating Antibiotic Associated Complications | 2021-04-08 |
20210100823 | USE OF GINSENOSIDE M1 FOR TREATING HUNTINGTON'S DISEASE | 2021-04-08 |
20210100824 | NGNA COMPOSITIONS AND METHODS OF USE | 2021-04-08 |
20210100825 | CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS | 2021-04-08 |
20210100826 | ACTIVATION OF P2X7 RECEPTORS WITH NON-BZBZ ADENOSINE TRIPHOSPHATE DERIVATIVES | 2021-04-08 |
20210100827 | COMBINED ADMINISTRATION OF CYSTEINE-ASPARTIC PROTEASE INHIBITORS WITH P2Y12 RECEPTOR ANTAGONISTS PROTECTS THE HEART AGAINST MYOCARDIAL INFARCTION | 2021-04-08 |
20210100828 | Methods for Treatment of Alport Syndrome | 2021-04-08 |
20210100829 | RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION | 2021-04-08 |
20210100830 | STARCH-BASED HEMOSTATIC POWDER AND PREPARATION METHOD THEREOF | 2021-04-08 |
20210100831 | POLYDEXTROSE FOR THE TREATMENT OF INFLAMMATORY DISEASES | 2021-04-08 |
20210100832 | INJECTABLE COMPOSITION FOR THE TREATMENT OF MUSCULOSKELETAL DISORDERS AND METHODS OF USE THEREOF | 2021-04-08 |
20210100833 | SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2021-04-08 |
20210100834 | COMPOSITION CONTAINING A CHLORIDE SALT FOR USE IN PREGNANT ANIMALS | 2021-04-08 |
20210100835 | COMPOSITIONS AND METHODS FOR ENHANCING ION TRANSPORTER ACTIVITY AND USES THEREOF | 2021-04-08 |
20210100836 | MATERIALS AND METHODS FOR PREVENTION AND TREATMENT OF DIARRHEA AND INFLAMMATION IN THE GASTROINTESTINAL TRACT | 2021-04-08 |
20210100837 | TREATMENT OF FIBROSIS WITH GENETICALLY-ENGINEERED MACROPHAGES | 2021-04-08 |
20210100838 | HUMAN ANTIBODIES THAT BIND AND ARE INTERNALIZED BY MESOTHELIOMA AND OTHER CANCER CELLS | 2021-04-08 |
20210100839 | NEW UNIVERSAL CHIMERIC ANTIGEN RECEPTOR T CELLS SPECIFIC FOR CD22 | 2021-04-08 |
20210100840 | SINGLE-CHAIN AND MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF | 2021-04-08 |
20210100841 | PRESENTING CELL AND USE THEREOF IN CELL THERAPY | 2021-04-08 |
20210100842 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | 2021-04-08 |
20210100843 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | 2021-04-08 |
20210100844 | RAR SELECTIVE AGONISTS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2021-04-08 |
20210100845 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2021-04-08 |
20210100846 | USE OF PLATELETS IN TREATING INFECTIONS | 2021-04-08 |
20210100847 | STEM CELLS FOR THE TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY | 2021-04-08 |
20210100848 | METHODS AND COMPOSITIONS FOR HEMATOPOIETIC STEM CELL MOBILIZATION | 2021-04-08 |
20210100849 | Mammalian Lung Spheroids and Lung Spheroid Cells and Uses Thereof | 2021-04-08 |
20210100850 | BACILLUS-BASED COMPONENTS FOR INHIBITING OR DELAYING THE GROWTH OF ENTEROCOCCUS SPP. IN ANIMALS | 2021-04-08 |
20210100851 | BACILLUS BACTERIUM, INTERLEUKIN-22 PRODUCTION INDUCING AGENT, SKIN BARRIER FUNCTION ENHANCING AGENT | 2021-04-08 |
20210100854 | PREBIOTIC FORMULATIONS | 2021-04-08 |
20210100855 | MODIFIED ADENOVIRUSES | 2021-04-08 |
20210100856 | METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT | 2021-04-08 |